Philippines - English - FDA (Food And Drug Administration)

glaxosmithkline philippines, inc. - salbutamol (as sulfate) , guaifenesin - syrup - 1mg/50mg per 5ml

Israel - English - Ministry of Health

glaxo smith kline (israel) ltd - salbutamol as sulfate - syrup - salbutamol as sulfate 2 mg / 5 ml - salbutamol - salbutamol - relief of bronchospasm in bronchial asthma of all types,chronic bronchitis,efmphysema.

Philippines - English - FDA (Food And Drug Administration)

pediatrica inc - each 5ml syrup contains; salbutamol (as sulfate), guaifenesin - syrup - 1.0mg/50.0mg

Philippines - English - FDA (Food And Drug Administration)

888 pharma distributors - salbutamol (as sulfate) - syrup - 2mg/5ml

Philippines - English - FDA (Food And Drug Administration)

accord bio laboratories - salbutamol (as sulfate) - syrup - 2mg / 5ml

Philippines - English - FDA (Food And Drug Administration)

ritemed phils inc - salbutamol (as sulfate) - syrup - 2mg/5ml

Philippines - English - FDA (Food And Drug Administration)

the cathay drug co., inc.; distributor: the cathay drug co., inc. - salbutamol (as sulfate) , guaifenesin - syrup - 1mg/50mg per 5ml

Australia - English - Department of Health (Therapeutic Goods Administration)

amneal pharma australia pty ltd - salbutamol sulfate -

Australia - English - Department of Health (Therapeutic Goods Administration)

amneal pharma australia pty ltd - salbutamol sulfate -

New Zealand - English - Medsafe (Medicines Safety Authority)

glaxosmithkline nz limited - salbutamol sulfate 0.48 mg/ml equivalent to 0.4 mg/ml salbutamol (or 2 mg salbutamol per 5 ml);   - syrup - 2 mg/5ml - active: salbutamol sulfate 0.48 mg/ml equivalent to 0.4 mg/ml salbutamol (or 2 mg salbutamol per 5 ml)   excipient: citric acid monohydrate hypromellose orange flavour 17-42-8187 purified water saccharin sodium sodium benzoate sodium chloride sodium citrate dihydrate - ventolin syrup is indicated for the treatment or prevention of bronchospasm. it provides short acting bronchodilation in reversible airways obstruction due to asthma, chronic bronchitis and emphysema. bronchodilators should not be the only or main treatment in patients with persistent asthma. in patients with persistent asthma unresponsive to salbutamol, treatment with inhaled corticosteroids is recommended to achieve and maintain control. failing to respond to treatment with salbutamol may signal a need for urgent medical advice or treatment. ventolin syrup is suitable oral therapy for children or those adults who prefer liquid medicines.